Conference program focuses on criteria for endocrine disruptors, legal aspects and potential impacts on economy, ecology and health
EFSA’s work on endocrine disrupters is ongoing
EFSA gives update on their work on endocrine active substances and non-monotonic dose response; following up their Scientific Opinion of 2013
When the dose does not make the poison
Scientists comment on first proposal to integrate non-monotonic dose response in chemical risk assessment framework
EU policy on EDCs deliberately obstructed
New report reveals internal documents, details stakeholder activities in obstructing Commission work on endocrine disrupting chemicals
Coop Denmark rejects fluorinated food packaging
Coop Denmark removes microwave popcorn from shelves because packaging contains fluorinated substances
Low-dose BPA exposure has adverse effects on mammary cells
U.S. scientists show that low-dose BPA upregulates expression of c-Myc gene associated with variety of human cancers
Assessing perchlorate exposure in French infants
French study suggests that tolerable daily intake (TDI) for perchlorate could be exceeded in some children, sources of perchlorate must be fully identified to reduce exposure
Does EDC exposure contribute to acne development?
Greek researchers discuss potential contribution of EDCs to elevated androgens levels and possibly to acne development
Meetings on impact assessment to identify EDC criteria
EU Commission’s DG Sante to hold two roundtables on EDCs in April and May 2015 with Member States and MEPs respectively
EU Commission organizes conference on EDCs
One-day conference to take place on June 1, 2015 in Brussels